Autoimmune Pulmonary Alveolar Proteinosis Not Yet Recruiting Phase 3 Trials for Sargramostim (DB00020)
Also known as: Pulmonary Alveolar Proteinosis, Autoimmune / Autoimmune pulmonary alveolar proteinosis (disorder) / Alveolar proteinosis / Pulmonary Alveolar Proteinosis / Pulmonary alveolar proteinosis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0075037 (Autoimmune Pulmonary Alveolar Proteinosis) | Not Yet Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT06431776 | Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP). | Treatment |